FDA inspection
EyePoint Pharmaceuticals, Inc.: FDA inspection ending Feb 15, 2024
FDA inspection 1230113 · Watertown, MA
Key facts
| Inspection ID | 1230113 |
|---|---|
| Firm | EyePoint Pharmaceuticals, Inc. |
| FEI number | 3005508657 |
| Address | 480 Pleasant St Ste B300 |
| City | Watertown |
| State | MA |
| ZIP | 02472-2468 |
| Fiscal year | 2024 |
| Inspection end date | Feb 15, 2024 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 679747 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data